Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anas Alrwas"'
Autor:
Saif Aldeen AlRyalat, Khaled Al Oweidat, Khaled Ashouri, Mohammad Al-Essa, Abeer Yaseen, Athar Al-Rawashdeh, Anas Alrwashdeh, Ahmad Toumar, Osama El Khatib
Publikováno v:
F1000Research, Vol 9 (2022)
Background: Altmetrics measure the impact of journal articles by tracking social media, Wikipedia, public policy documents, blogs, and mainstream news activity, after which an overall Altmetric attention score (AAS) is calculated for every journal ar
Externí odkaz:
https://doaj.org/article/321e124d197b463b8d5df6c58c5562f9
Autor:
Mutasem Elfalah, Nesrin Sulyman, Anas Alrwashdeh, Sari Al Hajaj, Sonia Alrawashdeh, Asad Al-Rawashdeh, Saif Aldeen AlRyalat
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
Background Color vision deficiency describes the inability to distinguish certain shades of color. The aim of this study was to assess the impact of having color vision deficiency on the accuracy of distinguishing benign and malignant skin lesions by
Externí odkaz:
https://doaj.org/article/c293cc59ccb049a9816c991dc74fdd77
Autor:
Kevin B, Kim, Anas, Alrwas
Publikováno v:
Chinese clinical oncology. 3(3)
Mucosal melanoma is a rare, aggressive histologic subtype of malignant melanoma, and prognosis for patients with metastatic mucosal melanoma is very poor. In general, conventional cytotoxic agents alone or in combination with immunologic drugs have l
Autor:
Suzanne Cain, Agop Y. Bedikian, Wen-Jen Hwu, Kevin B. Kim, Anas Alrwas, Michael A. Davies, Patrick Hwu, Sapna Pradyuman Patel, Nicholas E. Papadopoulos, Scott E. Woodman, Tawania L Deburr, Roland L. Bassett
Publikováno v:
Melanoma research. 24(4)
The primary objective of this study was to determine the safety, toxicity, and maximum tolerated dose of nanoparticle albumin-bound (nab)-paclitaxel as part of biochemotherapy for metastatic melanoma and to determine whether substituting nab-paclitax
Autor:
Brandy Shattuck, Luis Marcos, Anas Alrwas, Shivang Mehta, Jorge R. Quesada, Harinder S. Juneja, Nghia D. Nguyen
Publikováno v:
Cancer genetics. 205(10)
We report an unusual case of a symptomatic patient who initially had high hemoglobin and low serum erythropoietin levels, fitting a clinical diagnosis of polycythemia vera. However, after treatment with hydroxyurea and serial phlebotomies had been st
Autor:
Wen-Jen Hwu, Suzanne Cain, Michael A. Davies, Patrick Hwu, Kevin B. Kim, Anas Alrwas, Agop Y. Bedikian, Nicholas E. Papadopoulos, Tawania L Deburr, Roland L. Bassett, Sapna Pradyuman Patel, Scott E. Woodman
Publikováno v:
Journal of Clinical Oncology. 30:e19009-e19009
e19009 Background: NP has shown anti-tumor activity in MM in a phase II trial. The objective of this study was to determine MTD of NP as part of BCT, consisted of cisplatin (C), temozolomide (T), interleukin-2 (IL2) and interferon-alpha (IFN). Second